Intervirology

Papers
(The TQCC of Intervirology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Relationship between Human Papillomavirus Prevalence and DNA Damage in Cervical Cancer Population in Gansu Province, China17
Rag2 Deficiency Enhances Susceptibility to Systemic Mouse Adenovirus Type 1 Infection16
Identification of Two Similar Novel HIV-1 Recombinant Forms (CRF01_AE/CRF07_BC) among Intravenous Drug Users in Guangxi, China14
The Regulation of Prototype Foamy Virus 5′Long Terminal Repeats and Internal Promoter by Endogenous Transcription Factors12
Updating on Roles of HIV Intrinsic Factors: A Review of Their Antiviral Mechanisms and Emerging Functions11
Low-Intensity Ultrasound as a Novel Strategy to Improve the Cytotoxic Effect of Oncolytic Reovirus on Colorectal Cancer Model Cells10
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles8
Combination Therapy with Secretome of Reovirus-Infected Mesenchymal Stem Cells and Metformin Improves Anticancer Effects of Irinotecan on Colorectal Cancer Cells in vitro7
HIV-HCV Coinfection: Prevalence and Treatment Outcomes in Malaysia6
Surveillance of Pathogens Causing Viral Diarrhea in Yichang in 2022 and 20236
Features of Pathobiology and Clinical Translation of Approved Treatments for Coronavirus Disease 20195
Challenges and Pragmatic Solutions for Assessing the Reliability of HIV-1 Viral Load Monitoring in Resource-Constrained Settings5
Porcine Endogenous Retrovirus Induces CXCL10 in Human Monocytes and Monocyte-Derived Primary Cells5
Molecular Detection of Parvovirus in Manchurian Chipmunks (<b><i>Tamias sibiricus asiaticus</i></b>) Captured in Korea5
Global prevalence of pre-existing antibodies against human adenoviruses, surveyed from 1962-20214
GSK-3β as a Potential Coordinator of Anabolic and Catabolic Pathways in Hepatitis C Virus Insulin Resistance4
0.11386299133301